31. Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer. (April 2023) Authors: Auclin, Edouard; Benitez-Montanez, Jose; Tagliamento, Marco; Parisi, Francesca; Gorria, Teresa; Garcia-Campelo, Rosario; Dempsey, Naomi; Pinato, David J.; Reyes, Roxana; Albarrán-Artahona, Víctor; Dall'Olio, Filippo; Soldato, Davide; Hendriks, Lizza; Nana, Frank Aboubakar; Tonneau, Marion; Lopez-... Journal: Lung cancer Issue: Volume 178(2023) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC). (March 2022) Authors: Bahig, Houda; Tonneau, Marion; Blais, Normand; Wong, Philip; Filion, Edith; Campeau, Marie-Pierre; Vu, Toni; Al-Saleh, Afnan; Tehfé, Mustapha; Florescu, Marie; Roberge, David; Masucci, Laura; Richard, Corentin; Menard, Cynthia; Routy, Bertrand Journal: Clinical and translational radiation oncology Issue: Volume 33(2022) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Tepotinib Efficacy in a Patient with Non‐Small Cell Lung Cancer with Brain Metastasis Harboring an HLA‐DRB1‐MET Gene Fusion. (8th September 2020) Authors: Blanc‐Durand, Félix; Alameddine, Raafat; Iafrate, Anthony J.; Tran‐Thanh, Danh; Lo, Ying‐Chun; Blais, Normand; Routy, Bertrand; Tehfé, Mustapha; Leduc, Charles; Romeo, Phillipe; Stephenson, Phillipe; Florescu, Marie Journal: Oncologist Issue: Volume 25:Number 11(2020) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation. (2nd January 2017) Authors: Routy, Bertrand; Letendre, Caroline; Enot, David; Chénard-Poirier, Maxime; Mehraj, Vikram; Séguin, Noémie Charbonneau; Guenda, Khaled; Gagnon, Kathia; Woerther, Paul-Louis; Ghez, David; Lachance, Silvy Journal: Oncoimmunology Issue: Volume 6:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1. (3rd June 2018) Authors: Derosa, Lisa; Routy, Bertrand; Kroemer, Guido; Zitvogel, Laurence Journal: Oncoimmunology Issue: Volume 7:Number 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. The intimate relationship between gut microbiota and cancer immunotherapy. (4th May 2019) Authors: Elkrief, Arielle; Derosa, Lisa; Zitvogel, Laurence; Kroemer, Guido; Routy, Bertrand Journal: Gut microbes Issue: Volume 10:Isuse 3(2019) Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review. (March 2021) Authors: Tonneau, Marion; Elkrief, Arielle; Pasquier, David; Paz Del Socorro, Thomas; Chamaillard, Mathias; Bahig, Houda; Routy, Bertrand Journal: Radiotherapy and oncology Issue: Volume 156(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer. (2nd December 2018) Authors: Ivagnès, Alexandre; Messaoudene, Meriem; Stoll, Gautier; Routy, Bertrand; Fluckiger, Aurélie; Yamazaki, Takahiro; Iribarren, Kristina; Duong, Connie P. M.; Fend, Laetitia; Caignard, Anne; Cremer, Isabelle; LeCesne, Axel; Adam, Julien; Honoré, Charles; Mir, Olivier; Chaigneau, Loïc; Berger, Anne; ... Journal: Oncoimmunology Issue: Volume 7:Number 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy. (1st January 2020) Authors: Daillère, Romain; Derosa, Lisa; Bonvalet, Mélodie; Segata, Nicola; Routy, Bertrand; Gariboldi, Manuela; Budinská, Eva; De Vries, I. Jolanda M.; Naccarati, Alessio Gordon; Zitvogel, Valérie; Caldas, Carlos; Engstrand, Lars; Loilbl, Sibylle; Fieschi, Jacques; Heinzerling, Lucie; Kroemer, Guido; Zit... Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy. (1st January 2020) Authors: Daillère, Romain; Derosa, Lisa; Bonvalet, Mélodie; Segata, Nicola; Routy, Bertrand; Gariboldi, Manuela; Budinská, Eva; De Vries, I. Jolanda M.; Naccarati, Alessio Gordon; Zitvogel, Valérie; Caldas, Carlos; Engstrand, Lars; Loilbl, Sibylle; Fieschi, Jacques; Heinzerling, Lucie; Kroemer, Guido; Zit... Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗